U-Blot® Blinatumomab Polyclonal AntibodyCat. No. WP26449Request quote
Size: 50μL/100μL
Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.
U-Blot® Blinatumomab Polyclonal AntibodyCat. No. WP26449
U-Blot® Secukinumab Polyclonal AntibodyCat. No. WP26448
U-Blot® Dinutuximab Polyclonal AntibodyCat. No. WP26447
U-Blot® Mepolizumab Polyclonal AntibodyCat. No. WP26446
U-Blot® Alirocumab Polyclonal AntibodyCat. No. WP26445
U-Blot® Idarucizumab Polyclonal AntibodyCat. No. WP26444
U-Blot® Necitumumab Polyclonal AntibodyCat. No. WP26443
U-Blot® Ixekizumab Polyclonal AntibodyCat. No. WP26442
U-Blot® Obiltoxaximab Polyclonal AntibodyCat. No. WP26441
U-Blot® Reslizumab Polyclonal AntibodyCat. No. WP26440
U-Blot® Olaratumab Polyclonal AntibodyCat. No. WP26439
U-Blot® Bezlotoxumab Polyclonal AntibodyCat. No. WP26438